LLY has been in the news 333% more than usual
Apr 17, 2025, 6:31 PM
-10.95%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
LLY has been in the news recently: Eli Lilly's obesity medication, orforglipron, demonstrated positive results in trials, helping patients lose an average of 16 pounds and reducing blood sugar levels by 1.3% to 1.6%. In contrast, Nvidia's stock recently fell 6% following a significant financial charge, reflecting broader market challenges.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.